Is establishing an appropriate bleeding risk profile in elderly patients treated with low-molecular-weight heparins needed?
Anton
Enrique
E
Marti
Juan
J
D000368:Aged; D003404:Creatinine / Q000097:blood; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D006470:Hemorrhage / Q000097:blood / Q000139:chemically induced*; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics; D006801:Humans; D007677:Kidney Function Tests; D008657:Metabolic Clearance Rate / Q000502:physiology; D012187:Retroperitoneal Space; D018570:Risk Assessment
D006495:Heparin, Low-Molecular-Weight; D003404:Creatinine